Keyword search (4,164 papers available)

"Hankins CA" Authored Publications:

Title Authors PubMed ID
1 Potential value streams of an integrated Canadian serosurveillance network Campbell JR; Russell WA; Wagner CE; Manuel DG; Anipindi V; Baral P; Evans TG; Hankins CA; Sander B; 40588636
CONCORDIA

 

Title:Potential value streams of an integrated Canadian serosurveillance network
Authors:Campbell JRRussell WAWagner CEManuel DGAnipindi VBaral PEvans TGHankins CASander B
Link:https://pubmed.ncbi.nlm.nih.gov/40588636/
DOI:10.17269/s41997-025-01075-9
Publication:Canadian journal of public health = Revue canadienne de sante publique
Keywords:COVID-19Global healthInfectious diseasePublic healthSerologySurveillance
PMID:40588636 Category: Date Added:2025-07-01
Dept Affiliation: CONCORDIA
1 Respiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, QC, Canada. jonathon.campbell@mcgill.ca.
2 Department of Medicine, McGill University, Montreal, QC, Canada. jonathon.campbell@mcgill.ca.
3 Department of Global and Public Health, School of Population and Global Health, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada. jonathon.campbell@mcgill.ca.
4 Department of Epidemiology, Biostatistics, and Occupational Health, School of Population and Global Health, McGill University, Montreal, QC, Canada.
5 Department of Bioengineering, McGill University, Montreal, QC, Canada.
6 Methodological and Implementation Research Program, The Ottawa Hospital Research Institute, Ottawa, ON, Canada.
7 Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto, ON, Canada.
8 Department of Global and Public Health, School of Population and Global Health, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada.
9 Office of Vice-President, Research, Innovation and Impact, Concordia University, Montreal, QC, Canada.
10 Health Systems & Policy Research Collaborative Centre, University Health Network, Toronto, ON, Canada.

Description:

The Government of Canada, through the COVID-19 Immunity Task Force (CITF), supported over 100 serosurveillance studies during the COVID-19 pandemic, building and strengthening the technical infrastructure necessary for a national serosurveillance network. The value of such a network extends beyond infectious disease surveillance to monitoring non-communicable diseases and chemical and environmental contaminants, advancing immunology and medicine, and contributing to national and international research and training. A serosurveillance network can contribute to skill development and retention of the health workforce and provide a platform to rapidly evaluate diagnostics for emerging pathogens. Although full linkage of health data across jurisdictions remains a challenge for such a serosurveillance network to realize its full potential, there are several value streams that make it a worthwhile goal to pursue: improving population health, supporting policy decisions, and facilitating research and diagnostic development. In the aftermath of the COVID-19 pandemic, an integrated pan-Canadian serosurveillance network is a crucial asset going forward.





BookR developed by Sriram Narayanan
for the Concordia University School of Health
Copyright © 2011-2026
Cookie settings
Concordia University